Fourth Mayo Clinic and Karolinska Institutet Joint Cancer Research Symposium

Time and date: June 22, 2023, 8:00–11:30 US CT / 3:00–6:30 CET

Location: Online via Zoom

Four flags: the Swedish, The United States, Maoy Clinic and also Karolinska Institutet.
Collaboration between Karolinska Institutet and Mayo Clinic. Photo: KI

Registration link



8:00-8:05 CT / 3:00-3:05 CET- Welcome

Matthew P. Goetz, M.D. and Jonas Bergh, M.D.

8:05–8:15 CT / 3:05–3:15 CET- Introductory Remarks 

Cheryl L. Willman, M.D., Mayo Clinic Professor of Pathology and Medicine Executive Director, Mayo Clinic Cancer Programs Director, Mayo Clinic Cancer Center and Annika Östman Wernerson,  Professor of Renal and Transplantation Science, President, Karolinska Institutet

8:15–8:45 CT / 3:15–3:45 CET - Artificial intelligence image-based model development and validation for long-term breast cancer risk assessment in Swedish and U.S. screening setting

Celine Vachon, Ph.D., and Mikael Eriksson, Ph.D.

8:45–9:15 CT / 3:45–4:15 CET - Mutant p53 as a target to improve response to immune checkpoint blockade

Keith Knutson, Ph.D., and Galina Selivanova, Ph.D.

9:15–9:30 CT / 4:15–4:30 CET- Break

9:30–10:00 CT / 4:30–5:00 CET - Pseudo-Mutant p53: a Predictor of Leukemic Transformation in Clonal Hematopoiesis

Mrinal Patnaik, M.B.B.S., and Klas Wiman, Ph.D.

10:00–10:30 CT / 5:00–5:30 CET - Multi-Omics Studies of BTK Inhibitor Resistance in Chronic Lymphocytic Leukemia

Neil Kay, M.D., and Richard Rosenquist, M.D., Ph.D.

10:30–11:00 CT / 5:30–6:00 CET- Development of targeted immunotherapy for malignant B cell lymphomas

Zhi Zhang Yang, M.D., and Qiang Pan-Hammarström, M.D., Ph.D.

11:00–11:15 CT / 6:00–6:15 CET- Closing Remarks

Matthew P. Goetz, M.D. and Jonas Bergh, M.D.

Content reviewer:
Dina Dabaghie